417 related articles for article (PubMed ID: 31996401)
1. Sputum microbiome profiling in COPD: beyond singular pathogen detection.
Ditz B; Christenson S; Rossen J; Brightling C; Kerstjens HAM; van den Berge M; Faiz A
Thorax; 2020 Apr; 75(4):338-344. PubMed ID: 31996401
[TBL] [Abstract][Full Text] [Related]
2. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
3. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
Lee SW; Kuan CS; Wu LS; Weng JT
PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
[TBL] [Abstract][Full Text] [Related]
4. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
[TBL] [Abstract][Full Text] [Related]
7. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
[TBL] [Abstract][Full Text] [Related]
8. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.
Millares L; Pascual S; Montón C; García-Núñez M; Lalmolda C; Faner R; Casadevall C; Setó L; Capilla S; Moreno A; Castro-Acosta AA; Alvarez-Martinez CJ; Sibila O; Peces-Barba G; Cosio BG; Agustí A; Gea J; Monsó E
BMC Pulm Med; 2019 Jun; 19(1):112. PubMed ID: 31234826
[TBL] [Abstract][Full Text] [Related]
10. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
[TBL] [Abstract][Full Text] [Related]
11. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
[TBL] [Abstract][Full Text] [Related]
13. Lung microbiome dynamics in COPD exacerbations.
Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
[TBL] [Abstract][Full Text] [Related]
14. Short term dynamics of the sputum microbiome among COPD patients.
Sinha R; Weissenburger-Moser LA; Clarke JL; Smith LM; Heires AJ; Romberger DJ; LeVan TD
PLoS One; 2018; 13(3):e0191499. PubMed ID: 29518088
[TBL] [Abstract][Full Text] [Related]
15. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
[TBL] [Abstract][Full Text] [Related]
16. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
F1000Res; 2023; 12():528. PubMed ID: 37928173
[No Abstract] [Full Text] [Related]
17. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
18. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
Wang J; Chai J; Sun L; Zhao J; Chang C
BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
[TBL] [Abstract][Full Text] [Related]
19. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
Su L; Qiao Y; Luo J; Huang R; Xiao Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
[TBL] [Abstract][Full Text] [Related]
20. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]